Project Details
Description
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-la (BIIB017) in Subjects with Relapsing Multiple Sclerosis
| Status | Finished |
|---|---|
| Effective start/end date | 5/1/09 → 3/31/13 |
Funding
- BIOGEN INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.